MWFCX Performance — NYLI Equity ETF Allocation Fund, Class C
Data updated: 2026-09-23
MWFCX returned +11.43% year to date and +21.35% over one year to Jul 2026. Annualised returns are +14.95% over 3 years and +8.09% over 5 years. Against its Alternative category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $152, against $168 for the category, and to $121 over one year, against $108. Volatility over the past three years was 12.87% a year. In the 12 months to Jul 2026 the fund took in a net $22.8M, and assets reached $166.80M.
MWFCX Growth of $100
What $100 invested in NYLI Equity ETF Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | MWFCX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $121 | $108 |
| 3 years (Aug 2023 – Jul 2026) | $152 | $168 |
| 5 years (Aug 2021 – Jul 2026) | $148 | $159 |
| Since data start (Jul 2020 – Jul 2026) | $206 | $189 |
MWFCX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.43% |
| 1 year | +21.35% |
| 3 years (annualised) | +14.95% |
| 5 years (annualised) | +8.09% |
MWFCX Annual Returns
Calendar-year total returns of NYLI Equity ETF Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +11.43% |
| 2025 | +17.05% |
| 2024 | +13.48% |
| 2023 | +18.17% |
| 2022 | −18.68% |
| 2021 | +17.56% |
| 2020 (Jul–Dec) | +23.38% |
MWFCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.1% | +1.2% | −5.9% | +9.5% | +4.6% | +0.6% | −1.5% | — | — | — | — | — |
| 2025 | +3.0% | −2.1% | −4.1% | −0.2% | +5.7% | +4.3% | +1.0% | +3.0% | +3.1% | +1.7% | +0.4% | +0.5% |
| 2024 | −0.1% | +3.9% | +3.2% | −4.2% | +4.3% | +1.0% | +2.8% | +1.2% | +2.1% | −1.8% | +5.3% | −4.5% |
| 2023 | +7.5% | −2.7% | +0.7% | +0.7% | −1.6% | +6.3% | +3.8% | −3.0% | −4.6% | −3.5% | +8.5% | +5.9% |
| 2022 | −5.6% | −2.0% | +1.7% | −8.2% | +0.5% | −8.6% | +7.9% | −3.9% | −9.5% | +7.8% | +6.7% | −5.0% |
| 2021 | −0.1% | +3.3% | +2.8% | +3.9% | +1.2% | +0.9% | +0.6% | +2.1% | −4.1% | +5.1% | −2.9% | +3.7% |
| 2020 | — | — | — | — | — | — | +4.9% | +5.6% | −3.0% | −2.0% | +11.9% | +4.7% |
MWFCX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.87%
- 3-year Sharpe ratio: 0.81 (vs 4.5% risk-free rate)
- Best month: +9.51% (Apr 2026)
- Worst month: −5.86% (Mar 2026)
MWFCX Fund Flows
Monthly money in and out of NYLI Equity ETF Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: $22.8M
- 12-month gross sales (incl. reinvestments): $43.8M
- Sales ÷ redemptions: 2.08×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.3M | $1.8M | $2.5M |
| Jun 2026 | $3.9M | $1.5M | $2.4M |
| May 2026 | $2.9M | $1.9M | $973K |
| Apr 2026 | $4.0M | $2.4M | $1.6M |
| Mar 2026 | $3.2M | $1.7M | $1.5M |
| Feb 2026 | $3.9M | $1.7M | $2.1M |
| Jan 2026 | $3.6M | $1.4M | $2.2M |
| Dec 2025 | $7.1M | $2.3M | $4.9M |
| Nov 2025 | $2.1M | $1.4M | $742K |
| Oct 2025 | $2.9M | $1.7M | $1.3M |
| Sep 2025 | $2.9M | $1.5M | $1.5M |
| Aug 2025 | $2.8M | $1.8M | $1.0M |
MWFCX Assets Under Management
Net assets of NYLI Equity ETF Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $166.80M |
| 2026-04-30 | $154.99M |
| 2026-01-31 | $143.01M |
| 2025-10-31 | $133.05M |
| 2025-07-31 | $119.54M |
| 2025-04-30 | $104.29M |
| 2025-01-31 | $106.50M |
| 2024-10-31 | $99.45M |
| 2024-07-31 | $96.28M |
| 2024-04-30 | $85.03M |
| 2024-01-31 | $77.39M |
| 2023-10-31 | $63.21M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.